PTGR1
Basic information
Region (hg38): 9:111549722-111599893
Previous symbols: [ "LTB4DH" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTGR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 21 | 4 | 1 |
Variants in PTGR1
This is a list of pathogenic ClinVar variants found in the PTGR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-111563194-A-T | not specified | Uncertain significance (Oct 31, 2023) | ||
9-111563210-A-G | not specified | Likely benign (Dec 14, 2023) | ||
9-111570117-T-C | not specified | Uncertain significance (Dec 06, 2022) | ||
9-111570119-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
9-111570132-G-A | Likely benign (May 21, 2018) | |||
9-111570150-G-A | not specified | Uncertain significance (May 26, 2023) | ||
9-111570156-C-T | not specified | Uncertain significance (Oct 05, 2021) | ||
9-111570173-C-T | not specified | Likely benign (Jul 13, 2021) | ||
9-111570207-G-A | not specified | Uncertain significance (Aug 12, 2024) | ||
9-111574740-G-T | not specified | Uncertain significance (Sep 16, 2021) | ||
9-111574743-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
9-111574755-T-C | not specified | Uncertain significance (Dec 22, 2023) | ||
9-111574782-T-C | not specified | Uncertain significance (Aug 28, 2024) | ||
9-111574812-C-T | not specified | Likely benign (Dec 02, 2022) | ||
9-111578812-T-C | not specified | Uncertain significance (Dec 26, 2023) | ||
9-111578830-G-A | not specified | Uncertain significance (Apr 10, 2023) | ||
9-111578867-T-C | not specified | Uncertain significance (May 09, 2022) | ||
9-111578879-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
9-111578882-C-T | not specified | Uncertain significance (Mar 27, 2023) | ||
9-111578905-T-C | not specified | Uncertain significance (Sep 11, 2024) | ||
9-111578941-A-G | not specified | Uncertain significance (Dec 06, 2022) | ||
9-111578960-A-G | Benign (Dec 05, 2017) | |||
9-111583487-C-A | not specified | Uncertain significance (Aug 12, 2021) | ||
9-111583516-C-T | not specified | Uncertain significance (Oct 12, 2024) | ||
9-111586028-G-C | not specified | Uncertain significance (Jan 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTGR1 | protein_coding | protein_coding | ENST00000407693 | 9 | 50134 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.54e-8 | 0.341 | 125517 | 0 | 231 | 125748 | 0.000919 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.412 | 164 | 180 | 0.914 | 0.00000913 | 2123 |
Missense in Polyphen | 41 | 46.604 | 0.87975 | 560 | ||
Synonymous | 0.364 | 62 | 65.8 | 0.943 | 0.00000351 | 650 |
Loss of Function | 0.669 | 13 | 15.9 | 0.819 | 6.66e-7 | 220 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000541 | 0.000539 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00171 | 0.00171 |
European (Non-Finnish) | 0.00133 | 0.00132 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000882 | 0.000882 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha. Has no activity towards PGE1, PGE2 and PGE2-alpha (By similarity). Catalyzes the conversion of leukotriene B4 into its biologically less active metabolite, 12-oxo-leukotriene B4. This is an initial and key step of metabolic inactivation of leukotriene B4. {ECO:0000250}.;
- Pathway
- Nuclear Receptors Meta-Pathway;NRF2 pathway;Metabolism of lipids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Glycine Serine metabolism;Synthesis of Lipoxins (LX);Metabolism;Biosynthesis of specialized proresolving mediators (SPMs);Fatty acid metabolism;sphingosine and sphingosine-1-phosphate metabolism
(Consensus)
Recessive Scores
- pRec
- 0.0989
Intolerance Scores
- loftool
- 0.955
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 61.73
Haploinsufficiency Scores
- pHI
- 0.0900
- hipred
- N
- hipred_score
- 0.380
- ghis
- 0.398
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0766
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptgr1
- Phenotype
Gene ontology
- Biological process
- leukotriene metabolic process;prostaglandin metabolic process;oxidation-reduction process;response to antineoplastic agent
- Cellular component
- cytoplasm;extracellular exosome
- Molecular function
- 2-alkenal reductase [NAD(P)] activity;13-prostaglandin reductase activity;15-oxoprostaglandin 13-oxidase activity